See how your answers relate to your colleagues'.


As discussed during Diabetes Technology Roundtable V, recent studies evaluating safety and effectiveness of a tubeless AID system in patients with type 1 diabetes demonstrated:
a. HbA1c was significantly reduced
b. Pediatric Time in Range improved by 3.7 hours/day after 3 months use
c. Hypoglycemia remained low
d. All of the above

Submit
cgmEDUCATION.net is supported by independent educational grants from Insulet Corporation, Madrigal Pharmaceuticals, MannKind Corporation, Medtronic, and Tandem Diabetes Care, Inc.
©2025 CogniMed Inc. All rights reserved.